We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
(Approval lapsed) Methylphenidate Orifarm (methylphenidate hydrochloride) 10mg modified-release hard capsules (Sweden)
Section 19A approved medicine
(Approval lapsed) Methylphenidate Orifarm (methylphenidate hydrochloride) 10mg modified-release hard capsules (Sweden)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
RITALIN LA methylphenidate hydrochloride 10 mg modified release capsule bottle - ARTG 160228
RUBIFEN LA methylphenidate hydrochloride 10 mg modified release capsules blister pack - ARTG 362233
RUBIFEN LA methylphenidate hydrochloride 10 mg modified release capsules blister pack - ARTG 362233
Indication(s)
Methylphenidate hydrochloride modified release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and children aged 6 years and over.
Images
